This announcement is a separate document:
雅各臣科研製藥：須予披露交易 有關收購ORIZEN CAPITAL LIMITED的 43%已發行股本
Jacobson Pharma Corporation: DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 43% OF THE ISSUED SHARE CAPITAL OF ORIZEN CAPITAL LIMITED
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.